Table 4.
Subject | Age (year) | Gender |
Insulin level µlU/ml |
Anti‐insulin level U/ml |
C‐peptide level ng/ml |
Leptin level ng/ml |
---|---|---|---|---|---|---|
C01 | 14 | M | 9.0 | 6 | 1.0 | 3.5 |
C02 | 8 | M | 9.6 | 4.8 | 0.8 | 8.7 |
C03 | 11 | M | 2.3 | 9.8 | 0.8 | 1.0 |
C04 | 11 | M | 3.3 | 8.0 | 0.7 | 1.9 |
C05 | 13 | M | 9.9 | 3 | 0.9 | 1.1 |
C06 | 11 | M | 5.0 | 9.0 | 1.3 | 2.1 |
C07 | 14 | M | 8.2 | 8.0 | 0.5 | 6.5 |
C08 | 14 | M | 3.0 | 3.0 | 1.2 | 3.4 |
C09 | 14 | M | 4.6 | 3.0 | 1.3 | 2.0 |
C10 | 16 | M | 4.0 | 5.5 | 1.0 | 1.8 |
Mean | 12.6 | — | 5.89 | 6.01 | 0.95 | 3.2 |
Median | 13.5 | — | 4.8 | 5.75 | 0.95 | 2.05 |
Variance | 4.84 | — | 7.88 | 6.01 | 0.062 | 5.68 |
Minimum | 8 | — | 2.3 | 3 | 0.5 | 1 |
Maximum | 16 | — | 9.9 | 9.8 | 1.3 | 8.7 |
Range | 8 | — | 7.6 | 6.8 | 0.8 | 7.7 |